Cas 887338-46-7,3-bromo-4-fluoro-1-tosyl-1H-indole

887338-46-7

Post Buying Request

Basic information

Product Name: 3-bromo-4-fluoro-1-tosyl-1H-indole
Synonyms: 3-bromo-4-fluoro-1-tosyl-1H-indole
CAS NO:887338-46-7
Molecular Formula:
Molecular Weight: 368.226
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-bromo-4-fluoro-1-tosyl-1H-indole(CAS DataBase Reference)
NIST Chemistry Reference: 3-bromo-4-fluoro-1-tosyl-1H-indole(887338-46-7)
EPA Substance Registry System: 3-bromo-4-fluoro-1-tosyl-1H-indole(887338-46-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 887338-46-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

887338-46-7 Suppliers

Recommended suppliers

887338-46-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 887338-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,3,3 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 887338-46:
(8*8)+(7*8)+(6*7)+(5*3)+(4*3)+(3*8)+(2*4)+(1*6)=227
227 % 10 = 7
So 887338-46-7 is a valid CAS Registry Number.

887338-46-7Upstream product

887338-46-7Downstream Products

887338-46-7Relevant academic research and scientific papers

Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors

Yao, Chun-Hsu,Song, Jen-Shin,Chen, Chiung-Tong,Yeh, Teng-Kuang,Hsieh, Tsung-Chih,Wu, Szu-Huei,Huang, Chung-Yu,Huang, Yu-Lin,Wang, Min-Hsien,Liu, Yu-Wei,Tsai, Chi-Hui,Kumar, Chidambaram Ramesh,Lee, Jinq-Chyi

, p. 32 - 38,7 (2012)

Sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors are the current focus on the indication for the management of hyperglycemia in diabetes. Here, a novel series of C-linked indolylxyloside-based inhibitors of SGLT2 has been discovered. Structure-activity relationship studies revealed that substituents at the 7-position of the indole moiety and a p-cyclopropylphenyl group in the distal position were necessary for optimum inhibitory activity. The pharmacokinetic study demonstrates that the most potent compound 1i is metabolically stable with a low clearance in rats. In further efficacy study, 1i is found to significantly lower blood glucose levels of streptozotocin (STZ)-induced diabetic rats.

3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

-

, (2015/07/15)

The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

-

, (2014/03/22)

1-SUBSTITUTED-3- BETA-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME

-

Page/Page column 15, (2008/06/13)

A compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, etc. It is a 1-substituted-3-(β-D

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 887338-46-7